ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2024

Nov 16, 2024

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2024-09-30

Reporting Person: Lu Hongbo (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-22	Common Stock	P	400	$28	Acquired	34080	Direct
2024-03-26	Common Stock	P	850	$27.50	Acquired	34930	Direct
2024-04-02	Common Stock	P	150	$27.34	Acquired	35080	Direct
2024-04-10	Common Stock	P	500	$25	Acquired	35580	Direct
2024-04-18	Common Stock	P	500	$22	Acquired	36080	Direct
2024-09-25	Common Stock	G	5650	—	Disposed	30430	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5650	Indirect

Footnotes

F1: Includes previously reported restricted stock units, which are subject to certain vesting conditions.

F2: On September 25, 2024, the Reporting Person transferred 5,650 shares of the Issuer's common stock from a jointly-held retirement account to her spouse's individual retirement account for no consideration.